Perception and correlates of excessive vaginal discharge in rural women

Background: Vaginal discharge is one of the most common symptoms of gynecological morbidity. Vaginitis is the most prevalent cause. Gynecological disorders have substantial impact on female health and behaviour. Recent evidence suggests that the association between the complaint of vaginal discharge and the presence of Reproductive Tract Infections is weak. Women who are overanxious, introspective or suffering from fears of venereal disease and cancer tend to exaggerate the complaint of vaginal discharge into something pathological. The objective of the study was to study rural women’s perception and health care seeking behaviour regarding excessive vaginal discharge. To study various psychological and biological correlates of excessive vaginal dischargeMethods: This was a community based cross sectional study, conducted in the rural field practice areas under the Department of Community Medicine, Christian Medical College, Ludhiana. House to house surveys were conducted with semi-structured questionnaire and GAD 7 (Generalised Anxiety Disorder) scale, using systematic random sampling.Results: 160 rural women were interviewed to collect data. Of them, 27.5% reported having excessive vaginal discharge. There was no association observed between menstrual hygiene methods and excessive vaginal discharge (p= 0.77). Association couldn’t be observed with selection of barrier and other non-barrier methods of contraception (p= 0.09) either. Statistically significant association was observed between presence of anxiety and vaginal discharge (p=0.01).Conclusions: All vaginal discharges are not pathological. Causative factor of excessive vaginal discharge may not be infections always. There was a statistically significant association between anxiety and perceived vaginal discharge

International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module

We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2007-December 2012 in 503 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study using the Centers for Disease Control and Prevention's (CDC) U.S. National Healthcare Safety Network (NHSN) definitions for device-associated health care–associated infection (DA-HAI), we collected prospective data from 605,310 patients hospitalized in the INICC's ICUs for an aggregate of 3,338,396 days. Although device utilization in the INICC's ICUs was similar to that reported from ICUs in the U.S. in the CDC's NHSN, rates of device-associated nosocomial infection were higher in the ICUs of the INICC hospitals: the pooled rate of central line–associated bloodstream infection in the INICC's ICUs, 4.9 per 1,000 central line days, is nearly 5-fold higher than the 0.9 per 1,000 central line days reported from comparable U.S. ICUs. The overall rate of ventilator-associated pneumonia was also higher (16.8 vs 1.1 per 1,000 ventilator days) as was the rate of catheter-associated urinary tract infection (5.5 vs 1.3 per 1,000 catheter days). Frequencies of resistance of Pseudomonas isolates to amikacin (42.8% vs 10%) and imipenem (42.4% vs 26.1%) and Klebsiella pneumoniae isolates to ceftazidime (71.2% vs 28.8%) and imipenem (19.6% vs 12.8%) were also higher in the INICC's ICUs compared with the ICUs of the CDC's NHSN